National Biotechnology Centre (CNB-CSIC)
If you are the contact person for this centre and you wish to make any changes, please contact us.
Co-director of the Microbiome Analysis Laboratory and Research Professor
Co-director of the coronavirus group at the National Biotechnology Centre (CNB-CSIC)
Research professor at the National Biotechnology Centre (CNB-CSIC) and at the CIBERER-ISCIII
CNB-CSIC scientific researcher at the Instituto de Investigación Sanitaria de Santiago de Compostela, IDIS
Virologist at the National Center for Biotechnology (CNB-CSIC)
Researcher at the National Biotechnology Centre (CNB-CSIC)
Researcher specialized in ecology and evolution of antibiotic resistance.
Virologist at the National Biotechnology Centre (CNB-CSIC)
Two studies published in The Lancet Infectious Diseases confirm that covid-19 vaccines offer additional protection for those already infected with SARS-CoV-2, especially against severe disease.
La EMA ha recomendado hoy la autorización de la quinta vacuna frente a la covid-19 para mayores de 18 años: la estadounidense Novavax, la primera basada en una plataforma de proteínas recombinantes.
The new B.1.1.529 variant, dubbed Omicron, has spread across the globe, with new countries announcing its detection with each passing day. While questions such as whether it is more transmissible are being investigated, the biggest question surrounds its relationship with vaccines - will they cease to be effective, and will this variant escape our immune systems? Several experts answer.